ÂÜÀòÂÒÂ×

Steve Graunke is an accomplished professional with extensive experience in process development within the biopharmaceutical sector. Currently, Steve serves as Director of Process Development at Viridian Therapeutics, Inc., and has previously held key roles at Acceleron Pharma, Lonza, and Pfizer. With a strong foundation in manufacturing science and technology, Steve has led numerous development studies, focusing on purification processes and various downstream techniques. Steve's academic credentials include a Master's degree in Biomedical Engineering and a Bachelor's degree in Biological and Environmental Engineering, both from Cornell University. Prior educational involvement includes a tenure as a Science and Math Instructor at York County Community College.